HL

Hester Larkin

Radiopharm Theranostics Limited | Non-Executive Director
Ms Larkin has been a Director of Radiopharm since February 2022. She is currently the Managing Director of Hester Larkin Associates Consulting. Since 2008 in this role, she has been providing consulting services to diagnostic imaging, pharmaceutical and biotech companies in projects ranging from pre-clinical, clinical, submission to the European Medicines Agency, EU medical advisory boards, EU manufacturing and commercial partnerships. She has also held several board director and trustee positions in the United Kingdom and Belgium and currently sits on the board of directors of two charities.

Company and Role

Company
Title
Tenure
Since
RAD
RAD
Radiopharm Theranostics Limited
  • Non-Executive Director
4yrs, 5mthFeb 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
RAD
Radiopharm Theranostics Limited
30/06/25550,00094,24710,175,002N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
RAD
Radiopharm Theranostics Limited
16/12/24
Issued
8,000,000$0.027$216,000Issue of options
RAD
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
275,000$0.071$19,525Placement
RAD
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
550,000$0.040$22,000Placement
RAD
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
28,133$0.070$1,969Rights issue
RAD
RAD
Radiopharm Theranostics Limited
05/12/22
Issued
1,900,002$0.115$218,500Issue of options